Abstract：Objective To investigate the effect of Rosuvastatin on blood lipid,inflammatory factors and carotid atherosclerotic plaque in patients with cerebral infarction.Methods A total of 80 patients with acute cerebral infarction and carotid atherosclerotic plaque treated in our hospital from January 2017 to April 2018 were selected as the study objects,and divided into the observation group and control group by the random number table method,with 40 cases in each group.The observation group used Rosuvastatin,and the control group used Atorvastatin.The changes of blood lipid indexes and inflammatory factors between the two groups were compared,and the incidence of carotid plaque hemorrhage and plaque fibrous cap rupture were compared.Results The levels of lipid-related total cholesterol,triglyceride and low density lipoprotein the observation group were lower than those in the control group,and the level of high density lipoprotein was higher than that in the control group,the differences were statistically significant (P＜0.05).Three months after treatment,the levels of inflammatory factors such as hypersensitive C-reactiveprotein (hs-CRP) and interleukin-6 (IL-6) in the observation group were lower than those in the control group,and the differences were statistically significant (P＜0.05).One-year follow-up,the incidence rates of internal hemorrhage of carotid plaque and rupture of plaque fibrous cap in the observation group were lower than those in the control group,and the differences were statistically significant (P＜0.05).Conclusion For acute cerebral infarction,Rosuvastatin is an ideal lipidregulating agent,which can reduce the level of inflammatory response and reduce the incidence of plaque lesions.
Qiu Y，Wu Y，Meng M，et al.Rosuvastatin improves myocardial and neurological outcomes after asphyxial cardiac arrest and cardiopulmonary resuscitation in rats[J].Biomed Pharmacother，2017，87（4）：503-508.
京公网安备 11010502046607号